Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-29

FDA Approved: LAMOTRIGINE — Supplemental Application (Dr. Reddys Laboratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Inc., authorizing this generic Lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)